Alarm sounded over sustainability of wild plants used to treat Covid-19

TRAFFIC report about the essential but invisible trade: India among the top exporters

GN Bureau | June 19, 2020


#Covid-19   #coronavirus   #healthcare   #economy   #trade   #environment   #biodiversity   #IUCN  
Jatamansi (Nardostachys) in Lamteli Community Forest, Jumla, Nepal (Photo courtesy: ANSAB through TRAFFIC)
Jatamansi (Nardostachys) in Lamteli Community Forest, Jumla, Nepal (Photo courtesy: ANSAB through TRAFFIC)

Wild plant species used in herbal treatments of Covid-19 are set to come under heightened harvesting pressure, as a result of both increased demand and more people turning to wild harvesting as an alternative source of income during times of high unemployment and economic crisis, says a new TRAFFIC report.

From around the world, there are reports of herbal products containing wild plant ingredients being used to prevent and treat COVID-19 in South America, Africa, Europe, USA, and Asia, the organisation said in a press release from Cambridge on Thursday.

In China, official traditional Chinese medicine (‘TCM’) formulations used in the Covid-19 response utilise over 125 plant species, a selection of them wild harvested in China and beyond. They include Liquorice root (Glycyrrhiza spp), a protected species in parts of its Chinese range and several species whose international trade is regulated under the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) such as ginseng root Panax spp, Chinese Agarwood Aquilaria sinensis, and Golden Chicken Fern Cibotium barometz.

“Humankind’s dependence on wild plants for essential health care and well-being has never been more apparent than during the current Covid-19 pandemic,” said Anastasiya Timoshyna, TRAFFIC’s senior programme coordinator – sustainable trade, and co-chair of the International Union for Conservation of Nature (IUCN) Medicinal Plant Specialist Group.

“However, there is a complete lack of attention to the issues of sustainability in wild plant supplies.”

The new report, ‘The Invisible Trade: Wild plants and you in the times of COVID-19 and the essential journey towards sustainability’, draws attention to the economic, livelihood and conservation importance of the trade in wild plants alongside issues of the sustainability of supplies.

Around 26,000 plant species have well-documented medicinal uses globally. Around 3,000 of them are traded internationally, the majority (60–90%) believed to be wild-collected, says the report. But more than one in ten of the 19% of the species whose threat status was been assessed are at risk of extinction in the wild according to IUCN.

The minimum estimated value of the global trade in medicinal and aromatic plant species has almost tripled in recent years (from $1.3 billion in 1998 to $3.3 billion in 2018), according to the latest available UN Comtrade data. The world’s top exporters are China, India, Germany, USA and Hong Kong SAR, while the USA, Hong Kong SAR, Germany and Japan are the top importers.

The long-term availability of plant ingredients to support human health – through medicines, food and well-being products – is dependent on prioritising the conservation and sustainable use of the source species. The report identifies priority actions and recommendations to consumers, businesses, governments, as well as conservation and academic stakeholders.

Biodiversity conservation is critical in the ongoing preparation of the post-2020 Global Biodiversity Framework, and the sustainable and equitable trade in wild plant resource has the potential to provide a conservation and livelihoods “win-win” scenario.

Many common consumer products — herbal remedies, food, drink, cosmetics, supplements, and even furniture — come from wild harvested plants. Since 2008, TRAFFIC has partnered with the FairWild Foundation to promote the sustainable use of wild plant ingredients by applying the FairWild Standard throughout the herbal products supply chain.

Next week (June 22-26) is FairWild week, an annual online event to raise awareness about the importance of sustainable and equitable trade in wild plant ingredients. Taking part will be the FairWild Foundation and TRAFFIC alongside businesses such as Traditional Medicinals, Pukka Herbs and Neal’s Yard Remedies, whose products include several with FairWild certified ingredients, as well as educational and conservation organisations, including the Sustainable Herbs Program of the American Botanical Council, Botanic Gardens Conservation International, and WWF.

“Next week is a celebration of wild plants, the FairWild approach, and the tangible benefits that sustainable use brings to impoverished harvesting communities, to businesses responding to the rising consumer demand for sustainably sourced products and for conservation of the wild plants themselves. We hope you will join us on social media using the hashtag #FairWildWeek to shed light on this invisible but essential trade and support calls for action by businesses, governments and consumers,” said Timoshyna.

Comments

 

Other News

More tests, more oxygen: PM spells out focus

The expansion of the testing and treatment network and more availability of oxygen top the government’s priorities in combating the spread of Covid-19, prime minister Narendra Modi indicated on Tuesday. The PM chaired a video conference with the chief ministers of all states and UTs o

Now, mandatory Covid test to enter Maharashtra

From Wednesday, all passengers travelling to Maharashtra from the NCR of Delhi, Rajasthan, Gujarat and Goa – the four states with high numbers of Covid-19 infection in recent days – will have to compulsorily provide RT_PCR tests before boarding flights and trains.    

India’s active caseload remains below 5%, recovery rate remains above 93%

India’s present active caseload (4,43,486) is 4.85% of the total positive cases, and has been sustained below the 5% mark, the health ministry said in a bulletin Monday. The Recovery Rate continues to be above 93% as 93.68% of all cases have recovered as of date. In the 24 hours to Mon

Covid-19 too will be history one day: Dr. Harsh Vardhan

Covid-19 will soon be a “past episode”, Dr. Harsh Vardhan, minister for health and family welfare, has said, hoping that “vaccines available very soon, and the cases will significantly go down in the next few months”. “It is not the first one and definitely not

India’s reforms could support medium-term growth

The revival of the government’s reform agenda in response to the coronavirus pandemic shock has the potential to raise India’s medium-term growth rate, Fitch Ratings has said in a new analysis, while also taking note of downside pressures to growth and adding that it will take time to assess wh

Govt working towards resolving MSME issues through banking reforms: Patra

Acknowledging that much needs to be done in the banking sector, BJP national spokesperson Sambit Patra has said that the government was working on the nitty-gritties. “As far as the Indian banking system is concerned, a lot is still to be done and rest assured work is under progress. T



Archives

Current Issue

Opinion

Facebook    Twitter    Google Plus    Linkedin    Subscribe Newsletter

Twitter